ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.
What's Your Reaction?
